Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors
Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine
Immunology and immunotherapy approaches for prostate cancer
Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia
Use of interferon-alpha-induced dendritic cells in the therapy of patients with malignant brain gliomas
Antitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan-mediated motility mRNA in a mouse glioma model
Dendritic cell-based active specific immunotherapy for malignant glioma
Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells–a pilot study
In vitro induction of apoptosis in tumor cells by inactivated NDV and IAV
Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model
Monocyte-derived dendritic cell function in chronic hepatitis C is impaired at physiological numbers of dendritic cells
Persistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells
Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine
Hyperthermia-enhanced tumor accumulation and antitumor efficacy of a doxorubicin-conjugate with a novel macromolecular carrier system in mice with non-small cell lung cancer
Dendritic cell vaccines for leukemia patients
Dendritic cell-based immunotherapy of malignant melanoma: success and limitations
Re: Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase 1 clinical trial
Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus
Oncolytic virus therapy–foreword
Counterpoint: Hyperthermia with radiation therapy for chest wall recurrences